Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar 18;85(10):988-999.
doi: 10.1016/j.jacc.2024.11.025.

Clinical Effect of Genetic Testing in Inherited Cardiovascular Diseases: A 14-Year Retrospective Study

Steffany Grondin  1 , Benjamin Neveu  2 , Iness Soltani  1 , Ahmed Amine Alaoui  1 , Alexander Messina  1 , Laurence Gaumond  1 , Fabrice Demonière  1 , Ken Sin Lo  2 , Amélie Jeuken  1 , Catherine Barahona-Dussault  2 , Guillaume Sylvain-Drolet  2 , Laura Robb  2 , Johannie Gagnon  2 , Evelyne Naas  2 , Valérie-Anne Codina-Fauteux  2 , Diana Margarita Victoria Moron  2 , Sandra Therrien-Laperrière  2 , Valérie Hay  2 , Guillaume Lettre  1 , Marie-A Chaix  1 , Léna Rivard  1 , Geneviève Giraldeau  1 , Philippe L L'Allier  1 , Patrick Garceau  1 , Maxime Tremblay-Gravel  1 , Julia Cadrin-Tourigny  1 , Mario Talajic  1 , Julie Amyot  1 , Rafik Tadros  3
Affiliations

Clinical Effect of Genetic Testing in Inherited Cardiovascular Diseases: A 14-Year Retrospective Study

Steffany Grondin et al. J Am Coll Cardiol. .

Abstract

Background: The clinical impact of genetic testing in a contemporary real-life cohort of patients with heritable cardiomyopathies or arrhythmias is not well defined. Additionally, the genetic spectrum of these conditions in the French-Canadian population is unknown, and interpretation of genetic variants can be challenging because of a known founder effect.

Objectives: This study sought to evaluate the clinical utility of arrhythmia and cardiomyopathy genetic testing and assess the utility of allele frequency data from a local reference population.

Methods: The study included consecutive probands seen at the Montreal Heart Institute Cardiovascular Genetics Centre (Montreal, Quebec, Canada) for suspected heritable cardiomyopathies or arrhythmias for which both clinical data and genetic testing results were available. The study analyzed the enrichment of recurrent rare genetic variants by comparing their prevalence in the case cohort with that of a local population cohort.

Results: A total of 2,062 probands (mean age at diagnosis 47 ± 17 years) were included. Overall, genetic testing identified a pathogenic/likely pathogenic (P/LP) variant in 496 (24%) probands. A total of 9 variants had their classification changed after comparing their prevalence (case control enrichment) using a local population-based cohort. Genetic testing resulted in diagnostic refinement with a potential impact on clinical management in 168 (8%) probands.

Conclusions: Genetic testing in a clinical context identified a disease-causing variant in 24% of probands, thus highlighting the high yield of rare variant genetic testing. Beyond the impact on family screening, the genetic testing result affected clinical management. Access to allele frequency data from a local population refines variant interpretation and classification.

Keywords: arrhythmia; cardiomyopathy; cardiovascular genetics; founder effect; genetic testing.

PubMed Disclaimer

Conflict of interest statement

Funding Support and Author Disclosures This research has received support from the Philippa and Marvin Carsley Chair. Drs Lettre and Tadros have received support from the Canada Research Chairs program. Drs Chaix, Rivard, Tremblay-Gravel, and Cadrin-Tourigny have received support from the Fonds de Recherche du Québec en Santé. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.